“Effect of Upadacitinib on Biomarkers of Systemic Inflammation in Patients With Moderate-to-Severe Atopic Dermatitis”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s742. https://doi.org/10.25251/y5v7d428.